Veradigm reported $142.52M in Sales Revenues for its fiscal quarter ending in December of 2022.





Sales Change Date
Alcidion AUD 26.17M 701K Jun/2026
Ambu A/S DKK 1.7B 60M Sep/2026
Amplifon EUR 575M 31M Sep/2026
Cardinal Health USD 67.51B 3.81B Sep/2026
Centene USD 50.65B 2.93B Sep/2026
Charles River Laboratories USD 982.7M 17.3M Sep/2026
Cigna USD 73.7B 2B Sep/2026
Coloplast 7.04B 83M Dec/2025
Convatec Group USD 1.26B 80M Dec/2025
CVS Health USD 108.4B 2.3B Sep/2026
Diasorin EUR 308.05M 6.95M Sep/2026
Elevance Health USD 51.43B 1.63B Sep/2026
General Electric Aerospace USD 14.12B 1.49B Sep/2026
Gulf Medical Proj AED 194.39M 19.38M Mar/2026
Humana USD 41.16B 270M Sep/2026
IQVIA Holdings USD 4.43B 60M Sep/2026
Laboratory Of America USD 3.81B 80M Sep/2026
Max Healthcare Institute Limited 25.69B 4.13B Sep/2026
Maximus USD 1.28B 30M Jun/2026
McKesson USD 110.96B 5.58B Sep/2026
Med Life RON 853M 65.04M Mar/2026
Molina Healthcare USD 11.08B 212M Sep/2026
Omnicell USD 307.85M 4.36M Sep/2026
Oriola-kd EUR 53M 3.2M Sep/2026
Owens Minor USD 708.97M 11.71M Dec/2025
Quest Diagnostics USD 3.1B 57M Sep/2026
Rede D'or Sao Luiz BRL 15.52B 610M Sep/2026
Siemens Healthineers EUR 6.78B 1.02B Sep/2026
Sonova Holding CHF 1.82B 216.8M Dec/2025
Supermax Corporation Bhd MYR 217.3M 90.5M Jun/2026
UnitedHealth USD 112.69B 694M Sep/2026
Veeva Systems USD 927.96M 45.02M Jun/2026
Veradigm USD 142.52M 9.38M Dec/2022
Xerox USD 2.03B 160M Dec/2025